{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T15:46:32Z","timestamp":1771515992250,"version":"3.50.1"},"reference-count":54,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCR"],"published-print":{"date-parts":[[2019,5,6]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Cardiovascular diseases are the leading cause of death among dialysis patients,\naccounting for about 40% of all their mortalities. Sudden cardiac death (SCD) is culpable for\n37.5% of all deaths among patients with end-stage renal disease (ESRD). Implantable cardioverterdefibrillators\n(ICDs) should be considered in dialysis patients for the primary or secondary prevention\nof SCD. Recent studies on the implementation of ICD\/cardiac resynchronization therapy do\nnot exclude patients with ESRD; however, individualized decisions should be made in this group of\npatients. A thorough evaluation of the benefits of ICD implementation in patients with ESRD requires\nseveral large-scale mortality studies to compare and follow up patients with ESRD with and\nwithout ICDs. In the present study, we sought to determine and clarify the complications associated\nwith ICD implementation and management thereof in patients suffering from ESRD.\n<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>To assess the complications allied to the implementation of ICDs and their management\nin patients with ESRD, we reviewed available related articles in the literature.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results and Conclusions:<\/jats:title>\n<jats:p>ICD implementation in dialysis patients has several complications,\nwhich has limited its usage. Based on our literature review, the complications of ICD implementation\ncan be categorized as follows: (1) Related to implantation procedures, hematoma, and pneumothorax;\n(2) Related to the device\/lead such as lead fracture and lead dislodgment; (3) Infection;\nand (4) Central vein thrombosis. Hence, the management of the complications of ICDs in this specific\ngroup of patients is of vital importance.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573403x15666190118123754","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T06:48:05Z","timestamp":1547794085000},"page":"161-166","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Implantable Cardioverter-Defibrillators in Patients with ESRD: Complications, Management, and Literature Review"],"prefix":"10.2174","volume":"15","author":[{"given":"Bayati","family":"Mehdi","sequence":"first","affiliation":[{"name":"Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hosseini","family":"Kaveh","sequence":"additional","affiliation":[{"name":"Cardiology Resident, MS in Public Health, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasheghani-Farahani","family":"Ali","sequence":"additional","affiliation":[{"name":"Cardiac Primary Prevention, Research Center (CPPRC), Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","volume":"139","author":"Levey A.S.","year":"2003","unstructured":"Levey AS, Coresh J, Balk E. Ann Intern Med, National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification.,, 2003, 139,, 137-147,","journal-title":"Ann Intern Med"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/CIRCEP.110.937888","volume":"3","author":"Saravanan P.","year":"2010","unstructured":"Saravanan P, Davidson NC. Circ Arrhythm Electrophysiol, Risk assessment for sudden cardiac death in dialysis patients.,, 2010, 3,, 553-559,","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000464347","volume":"44","author":"Genovesi S.","year":"2017","unstructured":"Genovesi S, Porcu L, Luise MC. Blood Purif, Sudden death in end stage renal disease: Comparing hemodialysis versus peritoneal dialysis.,, 2017, 44,, 77-88,","journal-title":"Blood Purif"},{"key":"ref=4","first-page":"23062","volume":"2016","author":"Al-Khatib S.M.","year":"2016","unstructured":"Al-Khatib SM, Yancy CW, Solis P. J Am Coll Cardiol, 2016 AHA\/ACC clinical performance and quality measures for prevention of sudden cardiac death.,, 2016, 2016,, 23062-,","journal-title":"J Am Coll Cardiol"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0085-2538(15)50904-6","volume":"68","author":"Herzog C.A.","year":"2005","unstructured":"Herzog CA, Li S, Weinhandl ED, Strief JW, Collins AJ, Gilbertson DT. Kidney Int, Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators.,, 2005, 68,, 818-825,","journal-title":"Kidney Int"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jamainternmed.2017.8462","volume":"178","author":"Bansal N.","year":"2018","unstructured":"Bansal N, Szpiro A, Reynolds K. JAMA Intern Med, Long-term outcomes associated with implantable cardioverter defibrillator in adults with chronic kidney disease.,, 2018, 178,, 390-398,","journal-title":"JAMA Intern Med"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/pgmj.2010.208587rep","volume":"88","author":"Roberts P.R.","year":"2012","unstructured":"Roberts PR, Green D. Postgrad Med J, Republished article: Arrhythmias in chronic kidney disease.,, 2012, 88,, 97-104,","journal-title":"Postgrad Med J"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1016\/j.jacc.2015.10.022","volume":"66","author":"Cleland J.G.","year":"2015","unstructured":"Cleland JG, Mareev Y. J Am Coll Cardiol, CRT for heart failure and ESRD.,, 2015, 66,, 2630-2632,","journal-title":"J Am Coll Cardiol"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.amjcard.2010.06.058","volume":"106","author":"Hager C.S.","year":"2010","unstructured":"Hager CS, Jain S, Blackwell J, Culp B, Song J, Chiles CD. Am J Cardiol, Effect of renal function on survival after implantable cardioverter defibrillator placement.,, 2010, 106,, 1297-1300,","journal-title":"Am J Cardiol"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.joa.2017.05.002","volume":"33","author":"El\u2010Chami M.F.","year":"2017","unstructured":"El\u2010Chami MF, Matar L, Smith P. J Arrhythm, Long\u2010term survival of implantable cardioverter defibrillator recipients with end\u2010stage renal disease.,, 2017, 33,, 459-462,","journal-title":"J Arrhythm"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1540-8159.2007.00651.x","volume":"30","author":"Cuculich P.S.","year":"2007","unstructured":"Cuculich PS, S\u00e1nchez J, Kerzner R. Pacing Clin Electrophysiol, Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death.,, 2007, 30,, 207-213,","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/ndt\/gfu274","volume":"30","author":"Pun P.H.","year":"2015","unstructured":"Pun PH, Hellkamp AS, Sanders GD. Nephrol Dial Transplant, Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: A matched cohort study.,, 2015, 30,, 829-835,","journal-title":"Nephrol Dial Transplant"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1540-8167.2008.01258.x","volume":"19","author":"Amin M.S.","year":"2008","unstructured":"Amin MS, Fox AD, Kalahasty G, Shepard RK, Wood MA, Ellenbogen KA. J Cardiovasc Electrophysiol, Benefit of primary prevention implantable cardioverter\u2010defibrillators in the setting of chronic kidney disease: A decision model analysis.,, 2008, 19,, 1275-1280,","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000319461","volume":"32","author":"Hiremath S.","year":"2010","unstructured":"Hiremath S, Punnam SR, Brar SS. Am J Nephrol, Implantable defibrillators improve survival in end-stage renal disease: Results from a multi-center registry.,, 2010, 32,, 305-310,","journal-title":"Am J Nephrol"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"e99418","DOI":"10.1371\/journal.pone.0099418","volume":"9","author":"Chen T.H.","year":"2014","unstructured":"Chen TH, Wo HT, Chang PC, Wang CC, Wen MS, Chou CC. PLoS One, A meta-analysis of mortality in end-stage renal disease patients receiving implantable cardioverter defibrillators (ICDs).,, 2014, 9,, e99418-,","journal-title":"PLoS One"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"pii 989261","DOI":"10.4061\/2010\/989261","volume":"2010","author":"Cheema A.","year":"2010","unstructured":"Cheema A, Singh T, Kanwar M. Cardiol Res Pract, Chronic kidney disease and mortality in implantable cardioverter-defibrillator recipients.,, 2010, 2010,, pii 989261-,","journal-title":"Cardiol Res Pract"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.hrthm.2009.08.006","volume":"6","author":"Aggarwal A.","year":"2009","unstructured":"Aggarwal A, Wang Y, Rumsfeld JS, Curtis JP, Heidenreich PA, Registry NCD. Heart Rhythm, Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation.,, 2009, 6,, 1565-1571,","journal-title":"Heart Rhythm"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/j.ajkd.2011.03.026","volume":"58","author":"Charytan D.M.","year":"2011","unstructured":"Charytan DM, Patrick AR, Liu J. Am J Kidney Dis, Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States.,, 2011, 58,, 409-417,","journal-title":"Am J Kidney Dis"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.hrthm.2009.08.028","volume":"6","author":"Parkash R.","year":"2009","unstructured":"Parkash R. Heart Rhythm, Complications from implantable cardioverter defibrillator implantation: Do the risks outweigh the benefits?,, 2009, 6,, 1572-1573,","journal-title":"Heart Rhythm"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1540-8167.2011.02066.x","volume":"22","author":"Tompkins C.","year":"2011","unstructured":"Tompkins C, Mclean R, Cheng A. J Cardiovasc Electrophysiol, End\u2010stage renal disease predicts complications in pacemaker and ICD implants.,, 2011, 22,, 1099-1104,","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00001573-200101000-00010","volume":"16","author":"Pavia S.","year":"2001","unstructured":"Pavia S, Wilkoff B. Curr Opin Cardiol, The management of surgical complications of pacemaker and implantable cardioverter-defibrillators.,, 2001, 16,, 66-71,","journal-title":"Curr Opin Cardiol"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"c247","DOI":"10.1159\/000210001","volume":"111","author":"Fluck R.","year":"2009","unstructured":"Fluck R, Wilson J, Davies J, Blackburn R, O\u2019Donoghue D, Tomson C. Nephron Clin Pract, UK Renal Registry 11 Annual Report (December 2008): Chapter 12 Epidemiology of methicillin resistant Staphylococcus aureus bacteraemia amongst patients receiving renal replacement therapy in England in 2007.,, 2009, 111,, c247-c56,","journal-title":"Nephron Clin Pract"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1540-8167.2008.01191.x","volume":"19","author":"","year":"2008","unstructured":". J Cardiovasc Electrophysiol, AL\u2010Khatib SM, Hellkamp AS, Lee KL, et al. Implantable cardioverter defibrillator therapy in patients with prior coronary revascularization in the Sudden Cardiac Death in Heart Failure Trial (SCD\u2010HeFT).,, 2008, 19,, 1059-1065,","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1161\/CIRCULATIONAHA.110.959676","volume":"123","author":"Haines D.E.","year":"2011","unstructured":"Haines DE, Wang Y, Curtis J. Circulation, Implantable cardioverter-defibrillator registry risk score models for acute procedural complications or death after implantable cardioverter-defibrillator implantationclinical perspective.,, 2011, 123,, 2069-2076,","journal-title":"Circulation"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/jce.12435","volume":"25","author":"Buiten M.S.","year":"2014","unstructured":"Buiten MS, De Bie MK, Van Der Heijden AC. J Cardiovasc Electrophysiol, Chronic kidney disease and implantable cardioverter defibrillator related complications: 16 years of experience.,, 2014, 25,, 998-1004,","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref=26","first-page":"108","volume":"10","author":"Jacob S.","year":"2010","unstructured":"Jacob S, Bhandare D, Mathew A, Jahania MS. Indian Pacing Electrophysiol J, A Novel approach to ICD lead revision in a patient with extensive vascular thrombosis.,, 2010, 10,, 108-,","journal-title":"Indian Pacing Electrophysiol J"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/hrt.2003.025411","volume":"91","author":"Eberhardt F.","year":"2005","unstructured":"Eberhardt F, Bode F, Bonnemeier H. Heart, Long term complications in single and dual chamber pacing are influenced by surgical experience and patient morbidity.,, 2005, 91,, 500-506,","journal-title":"Heart"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1053\/j.ajkd.2007.02.272","volume":"49","author":"Dasgupta A.","year":"2007","unstructured":"Dasgupta A, Montalvo J, Medendorp S. Am J Kidney Dis, Increased complication rates of cardiac rhythm management devices in ESRD patients.,, 2007, 49,, 656-663,","journal-title":"Am J Kidney Dis"},{"key":"ref=29","first-page":"94","author":"Saad T.F.","year":"2015","unstructured":"Saad TF, Ahmed W, Davis K, Jurkovitz C. , Cardiovascular implantable\nelectronic devices in hemodialysis patients: Prevalence\nand implications for arteriovenous hemodialysis access interventions.\nSeminars in dialysis.,Wiley Online Library; , 2015"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1053\/j.ajkd.2011.05.005","volume":"58","author":"Drew D.A.","year":"2011","unstructured":"Drew DA, Meyer KB, Weiner DE. Am J Kidney Dis, Transvenous cardiac device wires and vascular access in hemodialysis patients.,, 2011, 58,, 494-496,","journal-title":"Am J Kidney Dis"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","volume":"346","author":"Moss A.J.","year":"2002","unstructured":"Moss AJ, Zareba W, Hall WJ. N Engl J Med, Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.,, 2002, 346,, 877-883,","journal-title":"N Engl J Med"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1111\/j.1540-8159.1989.tb01881.x","volume":"12","author":"Goudevenos J.A.","year":"1989","unstructured":"Goudevenos JA, Reid PG, Adams PC, Holden MP, Williams DO. Pacing Clin Electrophysiol, Pacemaker\u2010induced superior vena cava syndrome: Report of four cases and review of the literature.,, 1989, 12,, 1890-1895,","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref=33","first-page":"88","author":"Asif A.","year":"2012","unstructured":"Asif A, Carrillo R, Garisto JD. , Epicardial cardiac rhythm\ndevices for dialysis patients: minimizing the risk of infection and\npreserving central veins. Seminars in dialysis.,Wiley Online Library , 2012"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ccd.20326","volume":"65","author":"Bolad I.","year":"2005","unstructured":"Bolad I, Karanam S, Mathew D, John R, Piemonte T, Martin D. Catheter Cardiovasc Interv, Percutaneous treatment of superior vena cava obstruction following transvenous device implantation.,, 2005, 65,, 54-59,","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1148\/126.2.377","volume":"126","author":"Chamorro H.","year":"1978","unstructured":"Chamorro H, Rao G, Wholey MH. Radiology, Superior vena cava syndrome: A complication of transvenous pacemaker implantation 1.,, 1978, 126,, 377-378,","journal-title":"Radiology"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1053\/ajkd.2001.24527","volume":"37","author":"Tokars J.I.","year":"2001","unstructured":"Tokars JI, Light P, Anderson J. Am J Kidney Dis, A prospective study of vascular access infections at seven outpatient hemodialysis centers.,, 2001, 37,, 1232-1240,","journal-title":"Am J Kidney Dis"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000366453","volume":"40","author":"Opelami O.","year":"2014","unstructured":"Opelami O, Sakhuja A, Liu X, Tang WW, Schold JD, Navaneethan SD. Am J Nephrol, Outcomes of infected cardiovascular implantable devices in dialysis patients.,, 2014, 40,, 280-287,","journal-title":"Am J Nephrol"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/CIRCEP.108.795906","volume":"2","author":"de Oliveira J.C.","year":"2009","unstructured":"de Oliveira JC, Martinelli M, Nishioka SADO. Circ Arrhythm Electrophysiol, Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators.,, 2009, 2,, 29-34,","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.15420\/aer.2015.4.1.53","volume":"4","author":"Kennergren C.","year":"2015","unstructured":"Kennergren C. Arrhythm Electrophysiol Rev, Management of cardiovascular implantable electronic devices infections in high-risk patients.,, 2015, 4,, 53-,","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.hrthm.2015.08.003","volume":"12","author":"Guha A.","year":"2015","unstructured":"Guha A, Maddox WR, Colombo R. Heart Rhythm, Cardiac implantable electronic device infection in patients with end-stage renal disease.,, 2015, 12,, 2395-2401,","journal-title":"Heart Rhythm"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF03086202","volume":"16","author":"Bracke F.","year":"2008","unstructured":"Bracke F. Neth Heart J, Complications and lead extraction in cardiac pacing and defibrillation.,, 2008, 16,, 27-30,","journal-title":"Neth Heart J"},{"key":"ref=42","first-page":"582","author":"Asif A.","year":"2012","unstructured":"Asif A, Salman L, Lopera G, Haqqie SS, Carrillo R. , Transvenous\ncardiac implantable electronic devices and hemodialysis catheters:\nRecommendations to curtail a potentially lethal combination. Seminars\nin dialysis.,Wiley Online Library; 2012. p. 582-6"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s10016-003-0048-4","volume":"17","author":"Teruya T.H.","year":"2003","unstructured":"Teruya TH, Abou-Zamzam AM, Limm W, Wong L, Wong L. Ann Vasc Surg, Symptomatic subclavian vein stenosis and occlusion in hemodialysis patients with transvenous pacemakers.,, 2003, 17,, 526-529,","journal-title":"Ann Vasc Surg"},{"key":"ref=44","first-page":"p. 728-32","author":"Tan C.S.","year":"2013","unstructured":"Tan CS, Jie C, Joe J. The impact of transvenous cardiac devices\non vascular access patency in hemodialysis patients. Seminars\nin dialysis; 2013: Wiley Online Library, , , 2013","journal-title":"The impact of transvenous cardiac devices\non vascular access patency in hemodialysis patients Seminars\nin dialysis; 2013: Wiley Online Library"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/ki.2011.53","volume":"79","author":"Asif A.","year":"2011","unstructured":"Asif A, Salman LH, Lopera GG, Carrillo RG. Kidney Int, The dilemma of transvenous cardiac rhythm devices in hemodialysis patients: time to consider the epicardial approach?,, 2011, 79,, 1267-1269,","journal-title":"Kidney Int"},{"key":"ref=46","first-page":"671","author":"Asif A.","year":"2009","unstructured":"Asif A, Salman L, Carrillo RG. ASDIN: Patency rates for\nangioplasty in the treatment of pacemaker\u2010induced central venous\nstenosis in hemodialysis patients: Results of a multi\u2010center study.\nSeminars in dialysis,Wiley Online Library; 2009. p. 671-6","journal-title":"ASDIN: Patency rates for\nangioplasty in the treatment of pacemaker\u2010induced central venous\nstenosis in hemodialysis patients: Results of a multi\u2010center study\nSeminars in dialysis"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1053\/j.ajkd.2015.01.028","volume":"66","author":"Dhamija R.K.","year":"2015","unstructured":"Dhamija RK, Tan H, Philbin E. Am J Kidney Dis, Subcutaneous implantable cardioverter defibrillator for dialysis patients: A strategy to reduce central vein stenoses and infections.,, 2015, 66,, 154-158,","journal-title":"Am J Kidney Dis"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.hrthm.2009.05.020","volume":"6","author":"Wilkoff B.L.","year":"2009","unstructured":"Wilkoff BL, Love CJ, Byrd CL. Heart Rhythm, Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: This document was endorsed by the American Heart Association (AHA).,, 2009, 6,, 1085-1104,","journal-title":"Heart Rhythm"},{"key":"ref=49","first-page":"114","author":"Saad T.F.","year":"2013","unstructured":"Saad TF, Hentschel DM, Koplan B. Cardiovascular implantable\nelectronic device leads in CKD and ESRD patients: Review\nand recommendations for practice. Seminars in Dialysis,Wiley Online Library; 2013. p. 114-23","journal-title":"Cardiovascular implantable\nelectronic device leads in CKD and ESRD patients: Review\nand recommendations for practice Seminars in Dialysis"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1540-8159.2004.00378.x","volume":"27","author":"Feldman A.M.","year":"2004","unstructured":"Feldman AM, Klein H, Tchou P. Pacing Clin Electrophysiol, Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death.,, 2004, 27,, 4-9,","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jacc.2010.04.016","volume":"56","author":"Chung M.K.","year":"2010","unstructured":"Chung MK, Szymkiewicz SJ, Shao M. J Am Coll Cardiol, Aggregate national experience with the wearable cardioverter-defibrillator: Event rates, compliance, and survival.,, 2010, 56,, 194-203,","journal-title":"J Am Coll Cardiol"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1751-7133.2011.00214.x","volume":"17","author":"Adhyapak S.M.","year":"2011","unstructured":"Adhyapak SM, Iyengar SS. Congest Heart Fail, Characteristics of a subset of patients with reversible systolic dysfunction in chronic kidney disease.,, 2011, 17,, 120-126,","journal-title":"Congest Heart Fail"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/jce.12705","volume":"26","author":"","year":"2015","unstructured":". J Cardiovasc Electrophysiol, EL\u2010Chami MF, Levy M, Kelli HM, et al. Outcome of subcutaneous implantable cardioverter defibrillator implantation in patients with end\u2010stage renal disease on dialysis.,, 2015, 26,, 900-904,","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/jama.296.11.1377","volume":"296","author":"Coca S.G.","year":"2006","unstructured":"Coca SG, Krumholz HM, Garg AX, Parikh CR. JAMA, Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease.,, 2006, 296,, 1377-1384,","journal-title":"JAMA"}],"container-title":["Current Cardiology Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/169126","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T23:30:45Z","timestamp":1566257445000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/169126\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,6]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573403x15666190118123754","relation":{},"ISSN":["1573-403X"],"issn-type":[{"value":"1573-403X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-08-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}